Delving into the Latest Updates on Biosios (Beijing) Biotechnology Co., Ltd. with Synapse

Overview

Basic Info

Introduction

Baisios is a company that specializes in creating innovative cell therapy solutions for cancer treatment. With a strong commitment to advancing the field of tumor biotherapy, Baisios is at the forefront of developing new technologies to improve patient outcomes.

Tags

Nervous System Diseases

Cardiovascular Diseases

Other Diseases

Small molecule drug

Chemical drugs

Recombinant polypeptide

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	5
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Chemical drugs	2
Small molecule drug	1
Synthetic peptide	1
Recombinant polypeptide	1
Peptides	1

Top 5 Target	Count

AQP x AQP4	1
PSD95(Disks large homolog 4)	1
GPR37(G protein-coupled receptor 37)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Aug 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

2

1

Preclinical

Phase 1

1

Phase 3

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

BXOS-110 ( PSD95 )	Acute Ischemic Stroke More	Phase 3
BXOS-116	Acute Ischemic Stroke More	Phase 1
BXOS-401	Stroke More	Preclinical
WO2023237078 ( AQP x AQP4 )Patent Mining	Nervous System Diseases More	Discovery
WO2024222663 ( GPR37 )Patent Mining	Nervous System Diseases More	Discovery